Alvotech and Dr. Reddy’s have partnered up to launch AVT03, a biosimilar of Prolia and Xgeva, in the United States, Europe, and the United Kingdom.

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide (Alvotech), and Dr. Reddys Laboratories SA…

Read More: https://www.businesswire.com/news/home/20240521174553/en/